Abstract
Even after almost 15 years, polytetrafluoroethylene-covered stents are an important part of the armory of cardiac catheterization laboratory. They are invaluable in the emergent management of coronary perforations and are also used in the treatment of coronary aneurysms and fistulae. However, they are no longer routinely used in the treatment of saphenous venous graft disease. Future research may be aimed at premedicating them to effectively treat saphenous venous graft lesions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
